Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Genus Pharmaceuticals
Park View House, 65 London Road, Newbury, Berkshire, RG14 1JN
Telephone: +44 (0)1635 568 400
Fax: +44 (0)1635 568 401
Medical Information Direct Line: +44 (0)870 851 0207
Medical Information e-mail: genus@medinformation.co.uk
Customer Care direct line: +44 (0)1635 568 445
Medical Information Fax: +44 (0)1793 710 387

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/02/2012
PIL APO-go PFS 5mg/ml Solution for Infusion in Pre-filled Syringe

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
  • Change to manufacturer contact details
Updated on 28/09/2010 and displayed until 07/02/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 09/03/2010 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change of contra-indications
  • Change to warnings or special precautions for use
Updated on 03/02/2010 and displayed until 09/03/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Marketing Authorisation Holder
Updated on 18/09/2009 and displayed until 03/02/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 04/09/2009 and displayed until 18/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 18/02/2009 and displayed until 04/09/2009
Reasons for adding or updating:
  • Change of manufacturer
  • PIL Retired pending re-submission
Updated on 26/08/2008 and displayed until 18/02/2009
Reasons for adding or updating:
  • Change of manufacturer
Updated on 01/07/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Improved Electronic Presentation
Updated on 12/05/2006 and displayed until 01/07/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 25/05/2005 and displayed until 12/05/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/05/2005 and displayed until 25/05/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/04/2005 and displayed until 04/05/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  apomorphine hydrochloride